1. Home
  2. SRPT vs EXLS Comparison

SRPT vs EXLS Comparison

Compare SRPT & EXLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRPT
  • EXLS
  • Stock Information
  • Founded
  • SRPT 1980
  • EXLS 1999
  • Country
  • SRPT United States
  • EXLS United States
  • Employees
  • SRPT N/A
  • EXLS N/A
  • Industry
  • SRPT Biotechnology: Pharmaceutical Preparations
  • EXLS Business Services
  • Sector
  • SRPT Health Care
  • EXLS Consumer Discretionary
  • Exchange
  • SRPT Nasdaq
  • EXLS Nasdaq
  • Market Cap
  • SRPT 9.8B
  • EXLS 7.9B
  • IPO Year
  • SRPT 1997
  • EXLS 2006
  • Fundamental
  • Price
  • SRPT $70.40
  • EXLS $46.53
  • Analyst Decision
  • SRPT Buy
  • EXLS Strong Buy
  • Analyst Count
  • SRPT 21
  • EXLS 9
  • Target Price
  • SRPT $164.05
  • EXLS $46.33
  • AVG Volume (30 Days)
  • SRPT 2.2M
  • EXLS 1.2M
  • Earning Date
  • SRPT 04-30-2025
  • EXLS 05-01-2025
  • Dividend Yield
  • SRPT N/A
  • EXLS N/A
  • EPS Growth
  • SRPT N/A
  • EXLS 10.00
  • EPS
  • SRPT 2.34
  • EXLS 1.21
  • Revenue
  • SRPT $1,901,979,000.00
  • EXLS $1,838,372,000.00
  • Revenue This Year
  • SRPT $67.83
  • EXLS $14.01
  • Revenue Next Year
  • SRPT $25.66
  • EXLS $11.88
  • P/E Ratio
  • SRPT $30.71
  • EXLS $39.03
  • Revenue Growth
  • SRPT 52.97
  • EXLS 12.74
  • 52 Week Low
  • SRPT $70.91
  • EXLS $28.16
  • 52 Week High
  • SRPT $173.25
  • EXLS $52.43
  • Technical
  • Relative Strength Index (RSI)
  • SRPT 28.10
  • EXLS 48.22
  • Support Level
  • SRPT $70.91
  • EXLS $46.92
  • Resistance Level
  • SRPT $76.67
  • EXLS $48.03
  • Average True Range (ATR)
  • SRPT 4.03
  • EXLS 0.99
  • MACD
  • SRPT -1.50
  • EXLS 0.16
  • Stochastic Oscillator
  • SRPT 2.28
  • EXLS 68.02

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

About EXLS ExlService Holdings Inc.

ExlService Holdings Inc. is a business process management company that provides digital operations and analytical services to clients driving enterprise-scale business transformation initiatives that leverage company's deep expertise in analytics, AI, ML and cloud. The company offers business process outsourcing and automation services, and data-driven insights to customers across multiple industries. The company operates through four segments based on the products and services offered and markets served: Insurance, Healthcare, Emerging, Analytics. The vast majority of the company's revenue is earned in the United States, and more than half of its revenue comes from Analytics segment.

Share on Social Networks: